Study comparing two nerve block techniques to control pain after caesarean delivery.

Comparison of erector spinae plane block and transversus abdominis plane block with dexmedetomidine as adjuvant for post operative analgesia after caesarean section under spinal anaesthesia. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091511

Enrollment

Registered

2025-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Erector spinae plane block: The ESP blocks will be performed with patients in the right lateral decubitus position. Using USG correct space will be identified and confirmed.Bupivacaine

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists physical status II, or III normal singleton pregnancy (with a gestational age of at minimum 37 weeks) undergoing caesarean section under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Any contraindication to spinal anaesthesia (systemic coagulopathy, anatomic abnormalities, localized infection), known allergy to study medication, inability to comprehend or participate in pain scoring system.

Design outcomes

Primary

Measure	Time frame
To compare the analgesic efficacy of erector spinae plane block and transversus abdominis plane block with dexmedetomidine as adjuvant for post op analgesia after caesarean section under spinal anaesthesia by assessing the time for first rescue analgesia.Timepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, and 48 hours.	—

Secondary

Measure	Time frame
1.Visual analogue scale (resting & dynamic) will be assessed at rest & on movement at intervals of 6 hourly till 24 hours & the 12 hourly till 48 hours. (0,6,12,24,36,48 hours). Timepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;2.Total tramadol consumption for 48 hoursTimepoint: Calculated at the end of 48 hours.;3.Adverse effects if any like hypotension, bradycardia, sedation.Timepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;4.Severity of pain interference with performance of activities of daily living (ADL) breastfeeding, & general care (cleaning, changing, comforting) of the infant. ADLs assessed will include include changing position in bed, standing & walking, & eatingTimepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;5.Patient s overall satisfaction score at discharge using 0-5 score (0 = worst ,1= very bad, 2 = bad, 3 = good, 4 = very good, 5 = best).Timepoint: Assessed at time of discharge.	—

Measure

Time frame

1.Visual analogue scale (resting & dynamic) will be assessed at rest & on movement at intervals of 6 hourly till 24 hours & the 12 hourly till 48 hours. (0,6,12,24,36,48 hours). Timepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;2.Total tramadol consumption for 48 hoursTimepoint: Calculated at the end of 48 hours.;3.Adverse effects if any like hypotension, bradycardia, sedation.Timepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;4.Severity of pain interference with performance of activities of daily living (ADL) breastfeeding, & general care (cleaning, changing, comforting) of the infant. ADLs assessed will include include changing position in bed, standing & walking, & eatingTimepoint: Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours.;5.Patient s overall satisfaction score at discharge using 0-5 score (0 = worst ,1= very bad, 2 = bad, 3 = good, 4 = very good, 5 = best).Timepoint: Assessed at time of discharge.

—

Countries

India

Contacts

Public ContactDrRanju Gandhi

VMMC and Safdarjung Hospital

icu_era@yahoo.co.in9818941341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026